US Patent 7247300 Therapeutic use of soluble CD39L3
Patent 7247300 was granted and assigned to APT Therapeutics on July, 2007 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 7, 2003
1
Date of Patent
July 24, 2007
1
Patent Application Number
10703780
1
Patent Inventor Names
Ridong Chen
1
Soon S. Jeong
1
Timothy A. Mitsky
1
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7247300 Therapeutic use of soluble CD39L3
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.